Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA strand scission refers to the cleavage or breaking of the phosphodiester backbone of DNA, resulting in single-strand breaks (SSBs) or double-strand breaks (DSBs). This process can be induced by various chemical, enzymatic, and physical agents and is a critical event in both cellular damage responses and biotechnological applications. It plays a fundamental role in genetic recombination, repair processes, apoptosis, mutagenesis, and cytotoxicity, and is also exploited in genome editing and molecular cloning. Induction mechanisms include oxidative damage by reactive oxygen species, direct chemical reactions with DNA, metal complex-mediated cleavage, and enzymatic cleavage by endonucleases such as Cas9.
Directly breaking the phosphodiester bonds in the DNA backbone.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Strand Scission.